TAT-GluA2 3Y acetate(1404188-93-7 free base)

TargetMol
Product Code: TAR-TP2111L
Supplier: TargetMol
CodeSizePrice
TAR-TP2111L-1mg1mg£235.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP2111L-5mg5mg£442.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP2111L-10mg10mg£615.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP2111L-25mg25mg£930.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP2111L-50mg50mg£1,219.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP2111L-100mg100mg£1,621.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
TAT-GluA2 3Y acetate is an inhibitor of AMPA receptor endocytosis. Induces increased hind paw withdrawal latencies following thermal and mechanical stimuli in rats. Also exhibits antinociceptive effects in a rat model of neuropathic pain. Rescues pentobarbital-induced memory retrieval deficits in a rat model of learning and memory.
CAS:
TP2111L
Formula:
C115H185N43O29
Molecular Weight:
2634.02
Pathway:
Neuroscience
Purity:
0.9943
SMILES:
CC(O)=O.O=C(O)CNC([C@H](CC1=CC=C(O)C=C1)NC([C@H](C(C)C)NC([C@H](CC(N)=O)NC([C@H](CC2=CC=C(O)C=C2)NC(CNC([C@H](CCC(O)=O)NC([C@H](CCCCN)NC([C@H](CC3=CC=C(O)C=C3)NC([C@H](CCCNC(N)=N)NC([C@H](CCCNC(N)=N)NC([C@H](CCCNC(N)=N)NC([C@H](CCC(N)=O)NC([C@H](CCCNC(N)=N)NC([C@H](CCCNC(N)=N)NC([C@H](CCCCN)NC([C@H](CCCCN)NC([C@H](CCCNC(N)=N)NC(CNC([C@H](CC4=CC=C(O)C=C4)N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
Target:
GluR

References

Choi FY, et al. Interference with AMPA receptor endocytosis: effects on behavioural and neurochemical correlates of amphetamine sensitization in male rats. J Psychiatry Neurosci. 2014 May;39(3):189-99.